Iris Dorbian
Apexian Pharmaceuticals, an Indiana-based clinical stage biotechnology company, has raised an undisclosed amount of Series A funding. Apexian's investors included Elevate Ventures.
TM3 Therapeutics, a developer of treatments for rare neurodegenerative and metabolic disorders, has named Dr. Peter Van Vlasselaer as chairman of its board of directors. Currently, he is the CEO of ARMO Biosciences. TM3's backers include Sofinnova Partners and INKEF Capital.
Sofinnova Partners, a European life sciences venture firm, has appointed Maina Bhaman as a partner. Previously, she worked at Touchstone Innovations where she was director of healthcare investment.
Y-mAbs Therapeutics Inc, a New York City and Denmark-based developer of cancer treatments, has raised $30 million in a private placement. The investors were Sofinnova Ventures and Scopia Capital Management.
ALO7, China's English language learning product and services provider, has raised $37.5 million in Series D financing. Legend Capital led this round with participation from GuoHe Capital, UG Investment, Qualcomm, New Oriental and Vickers Venture Partners.
UnitedHealthGroup's health services business Optum has launched Optum Ventures, a $250 million venture fund. Optum Ventures will focus on digital health companies.
Turner Imaging Systems, a developer of X-ray imaging systems, has raised an undisclosed amount of seed funding. Cavendish Impact Capital led the round.
Omniex Holdings Inc, an investment and trading infrastructure provider for the crypto-asset industry, has raised $5 million in seed funding. Wicklow Capital led the round with participation from other investors that include Sierra Ventures, Digital Currency Group, Clocktower Technology Ventures and ThirdStream Partners.
Holland, Michigan-based Genesis Innovation Group, a developer of medical device technologies, has launched a $10 million venture fund. Cultivate(MD) Capital Fund I will focus on backing early-stage healthcare companies, with a special emphasis on medical device and orthopedic technologies.
Root Ventures is seeking to raise $75 million for its second fund, according to an SEC filing. The San Francisco-based venture firm invests in hardware, development tools, and data science.